The Crisis and Opportunity in Rare Diseases
8VC stepped into life sciences to bridge the gap between groundbreaking biomedical innovation and real-world patient care. Our collaborations with visionary scientists have already begun transforming deadly diseases into manageable conditions, and in some cases, outright cures. Despite the immense potential of advanced diagnostics and therapies, however, rare disease medicine remains starkly underdeveloped. At their core, the unmet needs in rare diseases are not only scientific or medical challenges, but fundamental misalignments of commercial and societal incentives.